Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Tresiba® (insulin degludec) – Expanded Indication
December 19, 2016 – Novo Nordisk announced the FDA approval of Tresiba (insulin degludec) to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
